Search for: "Circle C Corp." Results 21 - 40 of 123
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Aug 2015, 1:45 am
C-151/15: Most predictable CJEU order ever? [read post]
31 Jan 2014, 9:04 am by Doug Cornelius
 But Clifford Chance is a Magic Circle with much bigger throw weight than most firms. [read post]
7 Sep 2010, 6:10 pm by Kelly
(Docket Report) US: Helicos Biosciences Corp files patent infringement suit against Pacific Biosciences of California in response to its manufacture and use of Single Molecule Real Time DNA sequencing technology (Patent Docs) US: Report predicts tough road ahead for some generics after Federal Circuit patent use code decisions (FDA Law Blog) Products Angiomax (Bivalirudin) – US: APP moves forward with appeal notice in Angiomax PTE litigation in light of PTO/FDA indecision: Medicines… [read post]
5 Mar 2010, 9:10 pm
The district court tried to square the circle by throwing out the obviousness finding. [read post]
17 Jul 2009, 2:29 pm
(Shrewsbury, MA; Giovanni Tropeano, President) 3 G Tax Corp. [read post]
28 Jul 2015, 3:46 am
 On 16 July the Court of Justice of the European Union (CJEU) delivered its judgment in Case C-170/13 Huawei Technologies Co. [read post]
14 Oct 2009, 1:06 pm by @ErikJHeels
(Taunton, MA; Marie Crossley, President) 2 Belsub Corp. [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners: PharmaStem … [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ… [read post]
9 Apr 2009, 9:27 am
(Patent Baristas) (The Invent Blog) RXP keeps on growing as five more companies sign the dotted line (IAM) How patent vulnerability impacts valuation (IP Frontline) Ensuring quality patents through a rigorous review process (IP Frontline) Ocean Tomo, IP Exchange International launch OTI.com for global IP market data (Philip Brooks' Patent Infringement Updates) Research circles, communities of practice and IP consciousness (IP finance) Trade secrets: front and center? [read post]